Skip to content

NEUROLOGIX INC/DE

company.status.inactive

CIK 356591fmd_1538FHPCHQ11GA52DF2J27V1W2Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2000 to Jun 30, 2011, 13 periods

Latest annual · FY2010

Millions
Net income
(10)

Latest quarter · Q2 FY2011

Millions
Operating income
(3)
Net income
(3)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2005 to FY2010
n/m

NEUROLOGIX INC/DE financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2010FY2009ChangeSource
Net income-$10.2 million-$13.5 million10-Q 2011-08-11 · proof
Total assets$9.7 million10-Q 2011-08-11 · proof
Total liabilities$13.8 million10-Q 2011-08-11 · proof
Cash and cash equivalents$8.1 million$9.6 million-16.4%10-Q 2011-08-11 · proof
What was NEUROLOGIX INC/DE's net income in fiscal 2010?
NEUROLOGIX INC/DE reported net income of -$10.2 million for fiscal 2010 (the year ended Dec 31, 2010), against -$13.5 million the year before. Source: the 10-Q filed with the SEC on Aug 11, 2011. SEC
What are NEUROLOGIX INC/DE's total assets?
As of Dec 31, 2010, NEUROLOGIX INC/DE reported total assets of $9.7 million. Source: the 10-Q filed with the SEC on Aug 11, 2011. SEC
What are NEUROLOGIX INC/DE's total liabilities?
As of Dec 31, 2010, NEUROLOGIX INC/DE reported total liabilities of $13.8 million. Source: the 10-Q filed with the SEC on Aug 11, 2011. SEC
What are NEUROLOGIX INC/DE's cash and cash equivalents?
As of Dec 31, 2010, NEUROLOGIX INC/DE reported cash and cash equivalents of $8.1 million, against $9.6 million a year earlier (-16.4%). Source: the 10-Q filed with the SEC on Aug 11, 2011. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:356591&period_type=annual&limit=5"

Information only, not investment advice.